GPC Biotech AG (NASDAQ: GPCB) and Agennix announced that the two oncology-focused biotechnology companies have signed a Business Combination Agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE